4.8 Article

Targeted DNA demethylation in vivo using dCas9-peptide repeat and scFv-TET1 catalytic domain fusions

Journal

NATURE BIOTECHNOLOGY
Volume 34, Issue 10, Pages 1060-1065

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nbt.3658

Keywords

-

Funding

  1. Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)
  2. Japan Agency for Medical Research and Development (AMED)
  3. AMED-CREST
  4. AMED
  5. [15K14452]
  6. Grants-in-Aid for Scientific Research [16K07137, 15K14452] Funding Source: KAKEN

Ask authors/readers for more resources

Despite the importance of DNA methylation in health and disease, technologies to readily manipulate methylation of specific sequences for functional analysis and therapeutic purposes are lacking. Here we adapt the previously described dCas9-SunTag for efficient, targeted demethylation of specific DNA loci. The original SunTag consists of ten copies of the GCN4 peptide separated by 5-amino-acid linkers. To achieve efficient recruitment of an anti-GCN4 scFv fused to the ten eleven (TET) 1 hydroxylase, which induces demethylation, we changed the linker length to 22 amino acids. The system attains demethylation efficiencies >50% in seven out of nine loci tested. Four of these seven loci showed demethylation of >90%. We demonstrate targeted demethylation of CpGs in regulatory regions and demethylation-dependent 1.7- to 50-fold upregulation of associated genes both in cell culture (embryonic stem cells, cancer cell lines, primary neural precursor cells) and in vivo in mouse fetuses.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available